U.S. flag

An official website of the United States government

NM_024675.4(PALB2):c.656A>G (p.Asp219Gly) AND Breast-ovarian cancer, familial, susceptibility to, 5

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
May 12, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV005359053.1

Allele description [Variation Report for NM_024675.4(PALB2):c.656A>G (p.Asp219Gly)]

NM_024675.4(PALB2):c.656A>G (p.Asp219Gly)

Gene:
PALB2:partner and localizer of BRCA2 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
16p12.2
Genomic location:
Preferred name:
NM_024675.4(PALB2):c.656A>G (p.Asp219Gly)
Other names:
p.D219G:GAC>GGC
HGVS:
  • NC_000016.10:g.23635890T>C
  • NG_007406.1:g.10468A>G
  • NM_024675.4:c.656A>GMANE SELECT
  • NP_078951.2:p.Asp219Gly
  • NP_078951.2:p.Asp219Gly
  • LRG_308t1:c.656A>G
  • LRG_308:g.10468A>G
  • LRG_308p1:p.Asp219Gly
  • NC_000016.9:g.23647211T>C
  • NM_024675.3:c.656A>G
  • Q86YC2:p.Asp219Gly
  • p.D219G
Protein change:
D219G
Links:
UniProtKB: Q86YC2#VAR_066362; dbSNP: rs45594034
NCBI 1000 Genomes Browser:
rs45594034
Molecular consequence:
  • NM_024675.4:c.656A>G - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Breast-ovarian cancer, familial, susceptibility to, 5 (BROVCA5)
Identifiers:
MONDO: MONDO:0957530; MedGen: C5830615; OMIM: 620442

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV005913298Department of Pathology and Laboratory Medicine, Sinai Health System
criteria provided, single submitter

(ACMG Guidelines, 2015)
Uncertain significance
(May 12, 2023)
germlineclinical testing

PubMed (10)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Breast Cancer Risk Genes - Association Analysis in More than 113,000 Women.

Breast Cancer Association Consortium, Dorling L, Carvalho S, Allen J, González-Neira A, Luccarini C, Wahlström C, Pooley KA, Parsons MT, Fortuno C, Wang Q, Bolla MK, Dennis J, Keeman R, Alonso MR, Álvarez N, Herraez B, Fernandez V, Núñez-Torres R, Osorio A, Valcich J, Li M, et al.

N Engl J Med. 2021 Feb 4;384(5):428-439. doi: 10.1056/NEJMoa1913948. Epub 2021 Jan 20.

PubMed [citation]
PMID:
33471991
PMCID:
PMC7611105

Germline mutations in the PALB2 gene are population specific and occur with low frequencies in familial breast cancer.

Hellebrand H, Sutter C, Honisch E, Gross E, Wappenschmidt B, Schem C, Deissler H, Ditsch N, Gress V, Kiechle M, Bartram CR, Schmutzler RK, Niederacher D, Arnold N, Meindl A.

Hum Mutat. 2011 Jun;32(6):E2176-88. doi: 10.1002/humu.21478. Epub 2011 Feb 24.

PubMed [citation]
PMID:
21618343
See all PubMed Citations (10)

Details of each submission

From Department of Pathology and Laboratory Medicine, Sinai Health System, SCV005913298.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (10)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Jul 13, 2025